查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1627931

2024 - 2032 年電子藥品市場機會、成長動力、產業趨勢分析與預測

E-pharmacy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

到 2023 年，全球電子藥局市場價值將達到 862 億美元，預計 2024 年至 2032 年複合年成長率將達到 13.3%。產品以及獲取相關服務。這些數位平台提供無與倫比的便利性、隱私性和可訪問性，讓客戶將藥物直接送到家門口。

由於對便捷、可及的醫療保健解決方案的需求不斷成長，該市場正在快速成長。網路連線的擴展、智慧型手機的廣泛採用以及對數位醫療服務的日益偏好，大大簡化了線上取得藥物的過程。這種轉變在管理慢性病和經常性處方方面尤其明顯，這些疾病擴大透過電子藥局處理。

市場分為兩類：非處方藥產品和處方藥。 OTC 產品引領市場，預計未來幾年將以 12.6% 的複合年成長率穩定成長。非處方藥產品的主導地位可歸因於消費者對自我藥療的日益偏好以及無需處方即可購買藥品的便利性。隨著各種易於在線獲取的藥物的出現，消費者擴大轉向電子藥房來滿足他們的非處方藥需求。慢性病盛行率的上升和人口老化推動了對非處方藥產品的需求。此外，網上購物的謹慎性和送貨上門的便利性也推動了這一成長。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 862 億美元
預測值 2,633 億美元
複合年成長率 13.3%

美國在北美電子藥局市場保持主導地位，預計在整個預測期內將繼續保持領先地位。該國受益於強大的醫療基礎設施、完善的監管框架以及數位醫療解決方案的高採用率。線上處方服務的普及以及藥物送貨上門的便利性極大地促進了電子藥局的廣泛採用。數位醫療技術的不斷進步以及對改善患者護理的日益關注確保美國仍將是全球電子藥房市場的關鍵參與者。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 全球網路使用者數量增加
      • 增加對基於網路和線上服務的訪問
      • 利潤豐厚的優惠和折扣以及輕鬆獲取在線處方藥
      • 老年人口基數不斷擴大，慢性病盛行率不斷上升
    • 產業陷阱與挑戰
      • 非法網路藥局數量不斷增加
      • 假藥風險
  • 成長潛力分析
  • 監管環境
    • 美國
    • 歐洲
  • 網路藥局的現況與未來
  • 電子藥局商業模式
  • OTC 與 Rx 之間的分歧
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 非處方藥產品
  • 處方藥

第 6 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 比利時
    • 荷蘭
    • 挪威
    • 瑞士
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 印尼
    • 紐西蘭
    • 新加坡
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及
    • 伊朗

第 7 章：公司簡介

  • Capsule
  • Alto Pharmacy
  • Amazon
  • CVS Health
  • Express Scripts Holdings (Cigna)
  • Giant Eagle
  • MedsEngage
  • Optum Rx (UnitedHealth Group)
  • Rite Aid
  • The Kroger
  • Walgreens Boots Alliance
  • Walmart
簡介目錄
Product Code: 3303

The Global e-Pharmacy Market, valued at USD 86.2 billion in 2023, is projected to expand at a robust CAGR of 13.3% from 2024 to 2032. E-pharmacies are online platforms where consumers can easily purchase prescription and over-the-counter (OTC) medications and healthcare products and access related services. These digital platforms offer unparalleled convenience, privacy, and accessibility, allowing customers to have medications delivered directly to their doorsteps.

This market is growing rapidly, driven by the increasing demand for convenient, accessible healthcare solutions. The expansion of internet connectivity, widespread smartphone adoption, and a growing preference for digital health services have significantly simplified the process of accessing medications online. This shift is particularly evident in managing chronic conditions and recurring prescriptions, which are increasingly handled through e-pharmacies.

The market is divided into two categories: OTC products and prescription medicines. OTC products lead the market and are expected to grow at a steady rate of 12.6% CAGR over the coming years. The dominance of OTC products can be attributed to a growing consumer preference for self-medication and the convenience of purchasing medicines without a prescription. With a variety of easily accessible medications available online, consumers are increasingly turning to e-pharmacies for their OTC needs. The rising prevalence of chronic health conditions and the aging population drive the demand for OTC products. Additionally, the discreet nature of online purchases and the added convenience of home delivery fuel this growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$86.2 Billion
Forecast Value$263.3 Billion
CAGR13.3%

The United States maintains a dominant position in the North American e-pharmacy market and is expected to continue leading throughout the forecast period. The country benefits from a strong healthcare infrastructure, a well-established regulatory framework, and high adoption rates of digital health solutions. The popularity of online prescription services, in line with the convenience of having medications delivered to one's home, has significantly contributed to the widespread adoption of e-pharmacies. The ongoing advancements in digital health technology and the growing focus on improving patient care ensure that the U.S. will remain a key player in the global e-pharmacy market.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rise in the number of internet users worldwide
      • 3.2.1.2 Increasing access to web-based and online services
      • 3.2.1.3 Lucrative offers and discounts along with easy availability of online prescription drugs
      • 3.2.1.4 Expanding geriatric population base coupled with growing prevalence of chronic disorders
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Increasing number of illegal online pharmacies
      • 3.2.2.2 Risk of counterfeit drugs
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Current and future scenario of online pharmacies
  • 3.6 E-pharmacy market script volume, by payer mix, 2021-2032
  • 3.7 E-pharmacy business models
  • 3.8 Bifurcation between OTC and Rx
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 OTC products
  • 5.3 Prescription medicine

Chapter 6 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 UK
    • 6.3.3 France
    • 6.3.4 Spain
    • 6.3.5 Italy
    • 6.3.6 Russia
    • 6.3.7 Belgium
    • 6.3.8 Netherlands
    • 6.3.9 Norway
    • 6.3.10 Switzerland
  • 6.4 Asia Pacific
    • 6.4.1 Japan
    • 6.4.2 China
    • 6.4.3 India
    • 6.4.4 Australia
    • 6.4.5 South Korea
    • 6.4.6 Indonesia
    • 6.4.7 New Zealand
    • 6.4.8 Singapore
    • 6.4.9 Thailand
  • 6.5 Latin America
    • 6.5.1 Brazil
    • 6.5.2 Mexico
    • 6.5.3 Argentina
    • 6.5.4 Colombia
    • 6.5.5 Chile
  • 6.6 Middle East and Africa
    • 6.6.1 South Africa
    • 6.6.2 Saudi Arabia
    • 6.6.3 UAE
    • 6.6.4 Egypt
    • 6.6.5 Iran

Chapter 7 Company Profiles

  • 7.1 Capsule
  • 7.2 Alto Pharmacy
  • 7.3 Amazon
  • 7.4 CVS Health
  • 7.5 Express Scripts Holdings (Cigna)
  • 7.6 Giant Eagle
  • 7.7 MedsEngage
  • 7.8 Optum Rx (UnitedHealth Group)
  • 7.9 Rite Aid
  • 7.10 The Kroger
  • 7.11 Walgreens Boots Alliance
  • 7.12 Walmart